Breaking News

Tweet TWEET

Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013

  Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013

Business Wire

SUMMIT, N.J. -- April 03, 2013

Celgene Corporation (NASDAQ: CELG) senior management will host a conference
call and live audio webcast on Thursday, April 25, 2013 at 9 a.m. ET to
discuss the company’s first quarter 2013 financial and operational results.
The webcast will be available in the investor relations section of the
Company’s Web site at www.celgene.com.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit the company’s Web site at www.celgene.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally
statements that are not historical facts. Forward-looking statements can be
identified by the words "expects," "anticipates," "believes," "intends,"
"estimates," "plans," "will," “outlook” and similar expressions.
Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We
undertake no obligation to update any forward-looking statement in light of
new information or future events, except as otherwise required by law.
Forward-looking statements involve inherent risks and uncertainties, most of
which are difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of factors,
many of which are discussed in more detail in our Annual Report on Form 10-K
and our other reports filed with the Securities and Exchange Commission.

Contact:

Celgene Corporation
Jacqualyn A. Fouse, 908-673-9956
Executive Vice President and
Chief Financial Officer
or
Patrick E. Flanigan III, 908-673-9969
Vice President
Investor Relations
 
Press spacebar to pause and continue. Press esc to stop.